Skip to main content
CDNA
NASDAQ Industrial Applications And Services

CareDx Beats on Q3 Revenue of $139M and Lifts FY26 Revenue Guidance to $520M-$530M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$80.04
Mkt Cap
$3.7B
52W Low
$14.225
52W High
$73.43
52W Position info
463% above low
Off High info
at 52W high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

CDNA has more than doubled off its 52-week low of $14.225.

Summary

CareDx reported Q3 2026 revenue of $139 million (+39% year-over-year) and Adjusted EBITDA of $30 million, then raised full-year revenue guidance to $520-$530 million and Adjusted EBITDA guidance to $90-$100 million.


Key Events · Earnings and Guidance · CDNA

  • Q3 Revenue Up 39% to $139M

    Total revenue was $139.4 million versus $100.1 million a year ago; Testing Services revenue rose 65% to $119.2 million and Patient and Digital Solutions rose 31% to $20.2 million.

  • FY26 Guidance Raised Sharply

    Full-year 2026 revenue guidance moves to $520-$530 million from $490-$500 million, and Adjusted EBITDA guidance to $90-$100 million from $66-$78 million — a roughly 32% increase at the midpoint ($95M vs $72M).

  • Profitability Inflected

    GAAP net income was $19.3 million ($0.35 diluted) versus $1.7 million a year ago, and Adjusted EBITDA was $30.5 million (22% margin) versus $15.3 million (15% margin).

  • Prior-Period Catch-Up Inflates Growth

    Testing Services revenue includes $15 million recognized for tests performed in prior periods versus $6 million a year ago; excluding that, Testing Services revenue grew about 58%.


Analysis · CDNA · Industrial Applications And Services

The headline surprise is the EBITDA raise: CareDx lifted full-year Adjusted EBITDA guidance to $90-$100 million from $66-$78 million, putting the new midpoint of $95 million roughly 32% above the old midpoint of $72 million and implying management expects this quarter's margin expansion to hold. Revenue guidance moved to $520-$530 million from $490-$500 million. Third-quarter revenue grew 39% to $139 million, and Adjusted EBITDA more than doubled to $30 million. Testing Services revenue of $119 million, up 65%, includes $12 million from the Naveris/NavDx specialty oncology business acquired July 1, 2026, and $15 million of prior-period revenue recognition versus $6 million a year ago — so the underlying growth rate excluding prior-period catch-up is about 58%. With cash and equivalents of $250.5 million and $12.7 million of quarterly operating cash flow, this is a profitable-growth story rather than a financing one.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CDNA was trading at $80.04 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $14.23 to $73.43. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDNA - Latest Insights

CDNA
Oct 29, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $78.00
Real-time Price: $77.28 info
Change: -$0.7152 (-0.92%) info
Market Cap: $4.092B info
CDNA
Oct 29, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $71.49
Real-time Price: $77.28 info
Change: +$5.79 (+8%) info
Market Cap: $4.092B info
CDNA
Sep 16, 2026, 4:06 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $53.55
Real-time Price: $77.28 info
Change: +$23.73 (+44%) info
Market Cap: $4.092B info
CDNA
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $44.99
Real-time Price: $77.28 info
Change: +$32.29 (+72%) info
Market Cap: $4.092B info
CDNA
Aug 01, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $42.99
Real-time Price: $77.28 info
Change: +$34.29 (+80%) info
Market Cap: $4.092B info